Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -37.90% | -16.06% | -84.38% | 7.74% | -162.34% |
| Total Depreciation and Amortization | 10.27% | 4.91% | -0.53% | -4.60% | -27.04% |
| Total Amortization of Deferred Charges | 75.44% | 47.96% | 31.68% | -5.96% | -47.99% |
| Total Other Non-Cash Items | 52.46% | 75.32% | 617.83% | -7.52% | 105.70% |
| Change in Net Operating Assets | -105.43% | -90.69% | -26.75% | 14.92% | -67.45% |
| Cash from Operations | -159.87% | -59.29% | -4.66% | 22.93% | -3.37% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -150.61% | -46.77% | 74.26% | 22.55% | -61.27% |
| Cash from Investing | -136.71% | -107.58% | -85.83% | -64.79% | 36.85% |
| Total Debt Issued | 107.63% | 68.76% | 22.54% | 6.92% | -18.03% |
| Total Debt Repaid | -8.17% | -23.23% | -18.94% | -16.06% | 24.29% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 270.69% | 124.39% | 25.94% | -3.17% | -5.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | -- | -- |